Kaio Felippe Secchinato1, Pedro Henrique Rodrigues da Silva1, Júlia Palaretti1, and Renata Ferranti Leoni1
1Departamento de Física, University of São Paulo, Ribeirão Preto, Brazil
Synopsis
Early detection of Alzheimer's disease (AD) increases the
treatment benefits. However, it is still a challenging question which
biomarkers are useful for early diagnosis. Then, we aimed to classify cognitively
normal elderly regarding the possibility to develop AD based on resting-state cerebral
vasoreactivity (CVR) values and neuropsychological (NP) scores. We used
supervised machine learning algorithms. Our results suggest that Random Forest
and K-Nearest Neighbors classifiers trained with CVR values of the vermis.7
(part of the cerebellum), and left parahippocampal gyrus, and Mini-Mental State
Examination (MMSE), and Trail Making Test A scores can be useful on the early
detection of AD.
Introduction
The fact that AD starts 15 to
20 years before showing cognitive decline contributes to the difficulty of Alzheimer's
disease (AD) treatment1. There is still no pharmacological treatment
that slows or stops the disease progression2. Therefore, AD early
detection and diagnosis are essential. Alterations in cerebral perfusion have
been considered a promising early biomarker for AD since they are observed
before the clinical symptoms3. Cerebrovascular reactivity (CVR)4 may provide additional information. CVR measures cerebral
blood flow (CBF) increase after a vasodilator stimulus. Recently, the
feasibility of mapping CVR using resting-state functional magnetic resonance
imaging (rs-fMRI, rs-CVR), without vasodilator stimuli, has been shown5–7. Therefore, we aimed to investigate CVR alterations
in AD using machine learning. We hypothesized that regional CVR could be used
for the classification of the elderly who will develop AD.
Material and Methods
MRI data of 54 cognitively normal
subjects (CDR=0) was obtained from the publicly available Open Access Series of
Imaging Studies (OASIS3)8. Clinical Dementia Rating9 (CDR) scale was
used to define the groups:
twenty-seven subjects who progressed to AD (CDR=1) after MRI acquisition (age: 79.9±6.4 years, 13 males), and twenty-seven subjects who remained stable (age: 79.7±6.0 years, 13 males).
Scans were obtained on
BioGraph mMR PET-MR 3T by the Knight Alzheimer Research Imaging Program.
T1-weighted images and rs-fMRI were used. During the 6-minute rs-fMRI
acquisition, participants were asked to lay quietly, eyes open. RS-CVR index
was quantified for the AAL template10 following the previously published procedure5,6 and compared using t-test (p<0.05, corrected for
multiple comparisons).
Neuropsychological (NP) scores
of the Mini-Mental State Examination (MMSE), Digit Span, Category Verbal
Fluency (Animals and Vegetables), Trail Making Tests (TRAIL-A and TRAIL-B), Logical
Memory - Story A, WAIS and Boston were also considered.
We
performed a feature selection using the Boruta
method11 with Boruta package12 for R Software13 to reduce input
dimensionality and avoid redundant features to the predictive model. The collinearity between
the selected features was also assessed using Spearman's correlation14. We considered the following input parameters: NP
measures, CVR measures, and mixed measures (NP+CVR).
Seven classifiers were trained and
tested on the selected features with R language (3.3.2) using caret15: Random Forest (RF)16, Linear and Radial Support Vector
Machine (SVM)17, Naïve Bayes (NB)18, K-nearest neighbor (kNN)19 and an Artificial Neural Network
(ANN)20. Data were divided into sets for
training (70%) and testing (30%) using a 5-fold cross-validation method21. Receiver Operating Characteristic (ROC) was used
to select the optimal model using the highest value, except for the RF
algorithm. Results were analyzed using confusion matrix indicators to assess
the classifier's performance. Results
Figure 1 shows the average CVR
maps of both groups. No regional CVR difference was observed between groups. Groups
presented significant differences in MMSE (p = 0.028), and verbal fluency – category
vegetables (p = 0.022), and a trend for TRAIL-A (p = 0.091).
Boruta method provided MMSE
and TRAIL-A scores for NP measures only, and CVR values of Vermis.7 and right
Cerebelum.4.5 for CVR measures only. When considering NP and CVR measures, MMSE
and TRAIL-A scores, and CVR values of Vermis.7 and left ParaHippocampal gyrus were
selected.
Figure
2 shows the performance of the classifiers using the training set. Figure 3 shows the performance of the classifiers using the testing set. Discussion
The classification approach with
mixed measures (NP and CVR) achieved the best performance. MRI measurements involving the vermis (part of the
cerebellum)13–16 and parahippocampal gyrus26,27 were selected by the Boruta algorithm and have been
related to AD disease, although no study cited used CVR as a measure. The
cerebellum has been associated with verbal fluency28,29, which was the most affected NP score in our study,
although Boruta did not select it. In previous studies, TRAIL-A had the best
performance separating those who declined at an average or faster rate from
those who showed slower progression30,
while MMSE failed as a stand-alone
single-administration test for the identification of patients with mild
cognitive decline who could develop dementia31.
Considering the rs-CVR and NP scores, Linear SVM was
the less accurate approach, suggesting that our data is nonlinear. The improved
result obtained with nonlinear Radial SVM confirms this supposition. The best AUC was obtained by the RF approach,
based on lots of trees that
can ensure high accuracy. Similar performance was achieved by the KNN, which is
also considered as a weighted-neighborhoods
scheme32.Conclusion
Our results suggest that rs-
CVR and NP scores can be used with RF and KNN classifiers in early AD detection. Acknowledgements
Data were provided by OASIS-3:
Principal Investigators: T. Benzinger. D. Marcus. J. Morris; NIH P50AG00561.
P30NS09857781. P01AG026276. P01AG003991. R01AG043434. UL1TR000448. R01EB009352. References
1. Hippius,
H. & Neundörfer, G. The discovery of Alzheimer's disease. Dialogues
Clin. Neurosci. (2003) doi:10.31887/dcns.2003.5.1/hhippius.
2. Dubois, B. et al. Preclinical Alzheimer's disease:
Definition, natural history, and diagnostic criteria. Alzheimer’s and
Dementia (2016) doi:10.1016/j.jalz.2016.02.002.
3. Chen,
J. J. Cerebrovascular-reactivity mapping using MRI: Considerations for
Alzheimer's disease. Frontiers in Aging Neuroscience (2018)
doi:10.3389/fnagi.2018.00170.
4. Liu,
P., Vis, J. B. De & Lu, H. NeuroImage Cerebrovascular reactivity ( CVR )
MRI with CO2 challenge : A technical review. Neuroimage 1–12 (2018)
doi:10.1016/j.neuroimage.2018.03.047.
5. Liu,
P. et al. Cerebrovascular reactivity mapping without gas challenges. Neuroimage
(2017) doi:10.1016/j.neuroimage.2016.11.054.
6. Secchinato,
K. F., Da Silva, P. H. R., Camargo, A. P. A., Pontes-Neto, O. M. & Leoni,
R. F. Cerebrovascular reactivity mapping without hypercapnic challenge in
patients with carotid artery stenosis. Rev. Bras. Física Médica
(2019) doi:10.29384/rbfm.2019.v13.n2.p62-65.
7. Taneja, K. et al. Evaluation of cerebrovascular reserve
in patients with cerebrovascular diseases using resting-state MRI: A
feasibility study. Magn. Reson. Imaging (2019)
doi:10.1016/j.mri.2019.03.003.
8. LaMontagne,
P. J. et al. IC-P-164: OASIS-3: LONGITUDINAL NEUROIMAGING, CLINICAL, AND
COGNITIVE DATASET FOR NORMAL AGING AND ALZHEIMER'S DISEASE. Alzheimer's
Dement. (2018) doi:10.1016/j.jalz.2018.06.2231.
9. Berg,
L. Clinical Dementia Rating (CDR). Psychopharmacol. Bull. (1988).
10. Mutsaerts,
H. J. M. M. et al. Cerebral perfusion measurements in elderly with
hypertension using arterial spin labeling. PLoS One 10, 1–13
(2015).
11. Kursa,
M. B., Jankowski, A. & Rudnicki, W. R. Boruta - A system for feature
selection. Fundam. Informaticae (2010) doi:10.3233/FI-2010-288.
12. Kursa,
M. B. & Rudnicki, W. R. Feature selection with the boruta package. J.
Stat. Softw. (2010) doi:10.18637/jss.v036.i11.
13. R
Core Team. R: A Language and Environment for Statistical Computing. (2019).
14. Zar,
J. H. Spearman Rank Correlation. in Encyclopedia of Biostatistics
(2005). doi:10.1002/0470011815.b2a15150.
15. Kuhn,
M. & Contributions from Jed Wing, Steve Weston, Andre Williams, Chris
Keefer, Allan Engelhardt, Tony Cooper, Zachary Mayer, Brenton Kenkel, the R
Core Team, Michael Benesty, Reynald Lescarbeau, Andrew Ziem, Luca Scrucca, Yuan
Tang, Can Candan, and T. H. caret:
Classification and Regression Training. R Packag. version 6.0-79 (2018).
16. Breiman,
L. Random forests. Mach. Learn. (2001) doi:10.1023/A:1010933404324.
17. Cortes,
C. & Vapnik, V. Support-Vector Networks. Mach. Learn. (1995)
doi:10.1023/A:1022627411411.
18. Set,
A. Naive Bayes Classifiers. homepages.inf.ed.ac.uk (2009).
19. Peterson,
L. K-nearest neighbor. Scholarpedia (2009) doi:10.4249/scholarpedia.1883.
20. Dayhoff,
J. E. & DeLeo, J. M. Artificial neural networks: Opening the black box. in Cancer
(2001).
doi:10.1002/1097-0142(20010415)91:8+<1615::aid-cncr1175>3.0.co;2-l.
21. Refaeilzadeh,
P., Tang, L. & Liu, H. Cross-Validation. in Encyclopedia of Database
Systems (2009). doi:10.1007/978-0-387-39940-9_565.
22. Toniolo,
S. et al. Patterns of cerebellar gray matter atrophy across Alzheimer's
disease progression. Front. Cell. Neurosci. (2018)
doi:10.3389/fncel.2018.00430.
23. Mitelpunkt,
A. et al. Novel Alzheimer's disease subtypes identified using a data and
knowledge driven strategy. Sci. Rep. (2020)
doi:10.1038/s41598-020-57785-2.
24. Baldaçara,
L. et al. Relationship between structural abnormalities in the
cerebellum and dementia, posttraumatic stress disorder and bipolar disorder. Dement.
Neuropsychol. (2012) doi:10.1590/s1980-57642012dn06040003.
25. Jacobs,
H. I. L. et al. The cerebellum in Alzheimer's disease: Evaluating its
role in cognitive decline. Brain (2018) doi:10.1093/brain/awx194.
26. Echávarri,
C. et al. Atrophy in the parahippocampal gyrus as an early biomarker of
alzheimer's disease. Brain Struct. Funct. (2011)
doi:10.1007/s00429-010-0283-8.
27. Jacobs,
H. I. L. et al. Relevance of parahippocampal-locus coeruleus
connectivity to memory in early dementia. Neurobiol. Aging (2015)
doi:10.1016/j.neurobiolaging.2014.10.041.
28. Molinari,
M. & Leggio, M. Cerebellum and Verbal Fluency (Phonological and Semantic).
in The Linguistic Cerebellum (2016).
doi:10.1016/B978-0-12-801608-4.00004-9.
29. Lupo,
M. et al. Does the cerebellar sequential theory explain spoken language
impairments? A literature review. Clin. Linguist. Phonetics (2020)
doi:10.1080/02699206.2020.1745285.
30. Parikh,
M. et al. Single neuropsychological test scores associated with rate of
cognitive decline in early Alzheimer disease. Clin. Neuropsychol. (2014)
doi:10.1080/13854046.2014.944937.
31. Arevalo-Rodriguez,
I. et al. Mini-Mental State Examination (MMSE) for the detection of
Alzheimer's disease and other dementias in people with mild cognitive
impairment (MCI). Cochrane Database of Systematic Reviews (2015)
doi:10.1002/14651858.CD010783.pub2.
32. Lin,
Y. & Jeon, Y. Random forests and adaptive nearest neighbors. J. Am.
Stat. Assoc. (2006) doi:10.1198/016214505000001230.